. Vi and . Bibliographie,

, Agence de la biomédecine -rapport médical et scientifique

R. Fleming, D. B. Seifer, J. L. Frattarelli, and J. Ruman, Assessing ovarian response: antral follicle count versus anti-Müllerian hormone, Reprod Biomed Online, vol.31, issue.4, pp.486-96, 2015.

H. Li, V. Lee, E. Lau, W. Yeung, P. C. Ho et al., Role of baseline antral follicle count and anti-Mullerian hormone in prediction of cumulative live birth in the first in vitro fertilisation cycle: a retrospective cohort analysis, PloS One, vol.8, issue.4, p.61095, 2013.

G. J. Scheffer, F. Broekmans, C. Looman, M. Blankenstein, B. Fauser et al., The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age, Hum Reprod Oxf Engl. avr, vol.18, issue.4, pp.700-706, 2003.

K. R. Hansen, N. S. Knowlton, A. C. Thyer, J. S. Charleston, M. R. Soules et al., A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause, Hum Reprod Oxf Engl. mars, vol.23, issue.3, pp.699-708, 2008.

A. De-vet, J. Laven, F. H. De-jong, A. Themmen, and B. Fauser, Antimüllerian hormone serum levels: a putative marker for ovarian aging, Fertil Steril. févr, vol.77, issue.2, pp.357-62, 2002.

S. L. Broer, M. Dólleman, B. C. Opmeer, B. C. Fauser, B. W. Mol et al., AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis, Hum Reprod Update. févr, vol.17, issue.1, pp.46-54, 2011.

F. J. Broekmans, J. Kwee, D. J. Hendriks, B. W. Mol, and C. B. Lambalk, A systematic review of tests predicting ovarian reserve and IVF outcome, Hum Reprod Update. déc, vol.12, issue.6, pp.685-718, 2006.

C. Ferté-delbende, C. , S. Barrière, P. Dewailly, and D. ,

, J Gynecol Obstet Biol Reprod (Paris). déc, vol.39, issue.8, pp.27-33, 2010.

D. J. Hendriks, B. Mol, L. Bancsi, T. Velde, E. R. Broekmans et al., Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level, Fertil Steril. févr, vol.83, issue.2, pp.291-301, 2005.

S. L. Broer, B. Mol, D. Hendriks, and F. Broekmans, The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count, Fertil Steril. mars, vol.91, issue.3, pp.705-719, 2009.

K. Jayaprakasan, B. Campbell, J. Hopkisson, J. I. Raine-fenning, and N. , A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation, Fertil Steril. févr, vol.93, issue.3, pp.855-64, 2010.

V. Vernaeve, R. Soares, S. Budak, E. Bellver, J. Remohi et al.,

, Gynecol Obstet Fertil, vol.35, issue.10, pp.1015-1038, 2007.

R. Madankumar, M. A. Cohen, and S. H. Brenner, Age and fertility, Primary Care Update OB/GYNS, vol.10, pp.270-273, 2003.

J. P. De-bruin, M. Dorland, E. R. Spek, G. Posthuma, M. Van-haaften et al., Agerelated changes in the ultrastructure of the resting follicle pool in human ovaries, Biol Reprod. févr, vol.70, issue.2, pp.419-443, 2004.

F. J. Broekmans, M. R. Soules, and B. C. Fauser, Ovarian aging: mechanisms and clinical consequences, Endocr Rev. août, vol.30, issue.5, pp.465-93, 2009.

F. Pellestor, Frequency and distribution of aneuploidy in human female gametes, Hum Genet. janv, vol.86, issue.3, pp.283-291, 1991.

N. Maconochie, P. Doyle, S. Prior, and R. Simmons, Risk factors for first trimester miscarriage--results from a UK-population-based case-control study, BJOG Int J Obstet Gynaecol. févr, vol.114, issue.2, pp.170-86, 2007.

W. Wallace and T. W. Kelsey, Human ovarian reserve from conception to the menopause, PloS One. 27 janv, vol.5, issue.1, p.8772, 2010.

D. N. Lekamge, M. Barry, M. Kolo, M. Lane, R. B. Gilchrist et al., Anti-Müllerian hormone as a predictor of IVF outcome, Reprod Biomed Online. mai, vol.14, issue.5, pp.602-612, 2007.

B. P. Göksedef, N. Idi?, H. Görgen, Y. R. Asma, M. Api et al., The correlation of the antral follicle count and Serum anti-mullerian hormone, J Turk Ger Gynecol Assoc, vol.11, issue.4, pp.212-217, 2010.

T. Brodin, N. Hadziosmanovic, L. Berglund, M. Olovsson, and J. Holte, Comparing four ovarian reserve markers--associations with ovarian response and live births after assisted reproduction, Acta Obstet Gynecol Scand, vol.94, issue.10, pp.1056-63, 2015.

S. L. Broer, B. Mol, D. Hendriks, and F. Broekmans, The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count, Fertil Steril. mars, vol.91, issue.3, pp.705-719, 2009.

S. M. Nelson, R. W. Yates, H. Lyall, M. Jamieson, I. Traynor et al., Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception, Hum Reprod Oxf Engl. avr, vol.24, issue.4, pp.867-75, 2009.

S. Iliodromiti, T. W. Kelsey, O. Wu, R. A. Anderson, and S. M. Nelson, The predictive accuracy of anti-Müllerian hormone for live birth after assisted conception: a systematic review and metaanalysis of the literature, Hum Reprod Update. août, vol.20, issue.4, pp.560-70, 2014.

A. Gibreel, A. Maheshwari, S. Bhattacharya, and N. P. Johnson, Ultrasound tests of ovarian reserve; a systematic review of accuracy in predicting fertility outcomes, Hum Fertil Camb Engl. juin, vol.12, issue.2, pp.95-106, 2009.

G. J. Scheffer, F. Broekmans, L. F. Bancsi, J. Habbema, and C. Looman, Te Velde ER. Quantitative transvaginal two-and three-dimensional sonography of the ovaries: reproducibility of antral follicle counts, Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. sept, vol.20, issue.3, pp.270-275, 2002.

C. Weenen, J. Laven, V. Bergh, A. Cranfield, M. Groome et al., Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment, Mol Hum Reprod. févr, vol.10, issue.2, pp.77-83, 2004.

J. V. Jeppesen, R. A. Anderson, T. W. Kelsey, S. L. Christiansen, S. G. Kristensen et al., Which follicles make the most anti-Mullerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection, Mol Hum Reprod. août, vol.19, issue.8, pp.519-546, 2013.

M. Melo, N. Garrido, C. Alvarez, J. Bellver, M. Meseguer et al., Antral follicle count (AFC) can be used in the prediction of ovarian response but cannot predict the oocyte/embryo quality or the in vitro fertilization outcome in an egg donation program, Fertil Steril. janv, vol.91, issue.1, pp.148-56, 2009.

J. A. Grootegoed, W. M. Baarends, and A. P. Themmen, Welcome to the family: the anti-müllerian hormone receptor, Mol Cell Endocrinol. avr, vol.100, issue.1-2, pp.29-34, 1994.

A. Munsterberg and R. Lovell-badge, Expression of the mouse anti-Müllerian hormone gene suggests a role in both male and female sexual differentiation, Development, vol.113, issue.2, pp.613-637, 1991.

E. Rajpert-de-meyts, N. Jørgensen, N. Graem, J. Müller, R. L. Cate et al., Expression of anti-Müllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells, J Clin Endocrinol Metab, vol.84, issue.10, pp.3836-3880, 1999.

L. Marca, A. Broekmans, F. J. Volpe, A. Fauser, B. C. Macklon et al., Anti-Mullerian hormone (AMH): what do we still need to know?, ESHRE Special Interest Group for Reproductive Endocrinology--AMH Round Table, vol.24, issue.9, pp.2264-75, 2009.

A. Somunkiran, T. Yavuz, O. Yucel, and I. Ozdemir, Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome, Eur J Obstet Gynecol Reprod Biol, vol.134, issue.2, pp.196-201, 2007.

R. Fanchin, J. Taieb, D. Lozano, B. Ducot, R. Frydman et al., High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status, Hum Reprod Oxf Engl. avr, vol.20, issue.4, pp.923-930, 2005.

L. Marca, A. Giulini, S. Tirelli, A. Bertucci, E. Marsella et al., Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology, Hum Reprod Oxf Engl. mars, vol.22, issue.3, pp.766-71, 2007.

, Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary

A. Durlinger, J. A. Visser, and A. Themmen, Regulation of ovarian function: the role of anti-Müllerian hormone. Reprod Camb Engl, vol.124, pp.601-610, 2002.

S. Tsepelidis, I. Demeestere, A. Delbaere, C. Gervy, and Y. Englert, Anti-mullerian hormone and its role in the regulation of ovarian function

, Rev Med Brux. juin, vol.28, issue.3, pp.165-71, 2007.

D. Dewailly, C. Y. Andersen, A. Balen, F. Broekmans, N. Dilaver et al., The physiology and clinical utility of anti-Mullerian hormone in women, Hum Reprod Update. juin, vol.20, issue.3, pp.370-85, 2014.

C. Y. Andersen and A. G. Byskov, Estradiol and regulation of anti-Müllerian hormone, inhibin-A, and inhibin-B secretion: analysis of small antral and preovulatory human follicles' fluid, J Clin Endocrinol Metab, vol.91, issue.10, pp.4064-4073, 2006.

M. E. Kevenaar, A. Themmen, J. Laven, B. Sonntag, S. L. Fong et al., Anti-Müllerian hormone and anti-Müllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women, Hum Reprod Oxf Engl. juin, vol.22, issue.6, pp.1547-54, 2007.

M. M. Lee, P. K. Donahoe, T. Hasegawa, B. Silverman, G. B. Crist et al., Mullerian inhibiting substance in humans: normal levels from infancy to adulthood, J Clin Endocrinol Metab. févr, vol.81, issue.2, pp.571-577, 1996.

M. R. Sowers, A. D. Eyvazzadeh, D. Mcconnell, M. Yosef, M. L. Jannausch et al., Antimullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition, J Clin Endocrinol Metab. sept, vol.93, issue.9, pp.3478-83, 2008.

J. Van-disseldorp, M. J. Faddy, A. Themmen, F. H. De-jong, P. Peeters et al., Relationship of serum antimüllerian hormone concentration to age at menopause, J Clin Endocrinol Metab. juin, vol.93, issue.6, pp.2129-2163, 2008.

F. R. Tehrani, M. Solaymani-dodaran, and F. Azizi, A single test of antimullerian hormone in late reproductive-aged women is a good predictor of menopause, Menopause N Y N. août, vol.16, issue.4, pp.797-802, 2009.

L. Marca, A. Sighinolfi, G. Radi, D. Argento, C. Baraldi et al., Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART), Hum Reprod Update. avr, vol.16, issue.2, pp.113-143, 2010.

T. Ebner, M. Sommergruber, M. Moser, O. Shebl, E. Schreier-lechner et al., Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles, Hum Reprod Oxf Engl. août, vol.21, issue.8, pp.2022-2028, 2006.

K. Jayaprakasan, Y. Chan, R. Islam, Z. Haoula, J. Hopkisson et al., Prediction of in vitro fertilization outcome at different antral follicle count thresholds in a prospective cohort of 1,012 women, Fertil Steril. sept, vol.98, issue.3, pp.657-63, 2012.

A. Hazout, P. Bouchard, D. B. Seifer, P. Aussage, A. M. Junca et al., Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than folliclestimulating hormone, inhibin B, or estradiol, Fertil Steril, vol.82, issue.5, pp.1323-1332, 2004.

S. Cupisti, R. Dittrich, A. Mueller, R. Strick, E. Stiegler et al., Correlations between anti-müllerian hormone, inhibin B, and activin A in follicular fluid in IVF/ICSI patients for assessing the maturation and developmental potential of oocytes, Eur J Med Res. 14 déc, vol.12, issue.12, pp.604-612, 2007.

J. Smeenk, F. Sweep, G. A. Zielhuis, J. Kremer, C. Thomas et al., Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection, Fertil Steril. janv, vol.87, issue.1, pp.223-229, 2007.

L. Fong, S. Baart, E. B. Martini, E. Schipper, I. Visser et al., Anti-Müllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality?, Reprod Biomed Online. mai, vol.16, issue.5, pp.664-70, 2008.

F. Guerif, M. Lemseffer, M. Couet, O. Gervereau, V. Ract et al., Serum antimüllerian hormone is not predictive of oocyte quality in vitro fertilization, Ann Endocrinol. sept, vol.70, issue.4, pp.230-234, 2009.

A. Fournier, A. Torre, L. Delaroche, A. Gala, T. Mullet et al.,

, Gynecol Obstet Fertil Senol. août, vol.45, issue.7-8, pp.429-467, 2017.

T. Irez, P. Ocal, O. Guralp, M. Cetin, B. Aydogan et al., Different serum anti-Müllerian hormone concentrations are associated with oocyte quality, embryo development parameters and IVF-ICSI outcomes, Arch Gynecol Obstet, vol.284, issue.5, pp.1295-301, 2011.

G. Coticchio, E. Sereni, L. Serrao, S. Mazzone, I. Iadarola et al., What criteria for the definition of oocyte quality?, Ann N Y Acad Sci. déc, vol.1034, pp.132-176, 2004.

T. Ebner, M. Moser, and G. Tews, Is oocyte morphology prognostic of embryo developmental potential after ICSI?, Reprod Biomed Online. avr, vol.12, issue.4, pp.507-519, 2006.

T. Hoodbhoy and P. Talbot, Mammalian cortical granules: contents, fate, and function, Mol Reprod Dev. déc, vol.39, issue.4, pp.439-487, 1994.

P. May-panloup, M. Chrétien, Y. Malthièry, and P. Reynier,

, Med Sci MS. sept, vol.20, issue.8-9, pp.779-83, 2004.

G. Henrion, A. Brunet, J. P. Renard, and V. Duranthon, Identification of maternal transcripts that progressively disappear during the cleavage period of rabbit embryos, Mol Reprod Dev. août, vol.47, issue.4, pp.353-62, 1997.

E. Christians, V. H. Rao, and J. P. Renard, Sequential acquisition of transcriptional control during early embryonic development in the rabbit, Dev Biol. juill, vol.164, issue.1, pp.160-72, 1994.

H. Li, V. Lee, E. Lau, W. Yeung, P. C. Ho et al., Ovarian response and cumulative live birth rate of women undergoing in-vitro fertilisation who had discordant anti-Mullerian hormone and antral follicle count measurements: a retrospective study, PloS One, vol.9, issue.10, p.108493, 2014.

V. Klenov and E. Jungheim, AntiMullerian hormone (AMH) is a better predictor of response to controlled ovarian hyperstimulation (COH) than antral follicle count (AFC) in women with discordant markers of ovarian reserve, Fertil Steril. 1 sept, vol.106, issue.3, pp.123-127, 2016.

M. ?. Alebic, N. Stojanovic, and D. Dewailly, Discordance between serum anti-Müllerian hormone concentrations and antral follicle counts: not only technical issues, Hum Reprod Oxf Engl, vol.33, issue.6, pp.1141-1149, 2018.

A. Abbara, L. N. Vuong, V. Ho, S. A. Clarke, L. Jeffers et al., Follicle Size on Day of Trigger Most Likely to Yield a Mature Oocyte, Front Endocrinol, vol.9, p.193, 2018.

T. Freour, D. Masson, L. Dessolle, D. Allaoua, T. Dejoie et al., Ovarian reserve and in vitro fertilization cycles outcome according to women smoking status and stimulation regimen, Arch Gynecol Obstet. avr, vol.285, issue.4, pp.1177-82, 2012.

T. Freour, L. Dessolle, M. Jean, D. Masson, and P. Barriere, Predictive value of ovarian reserve markers in smoking and non-smoking women undergoing IVF, Reprod Biomed Online. juin, vol.20, issue.6, pp.857-60, 2010.

V. Rittenberg, S. Seshadri, S. K. Sunkara, S. Sobaleva, E. Oteng-ntim et al., Effect of body mass index on IVF treatment outcome: an updated systematic review and meta-analysis, Reprod Biomed Online, vol.23, issue.4, pp.421-460, 2011.

L. Bancsi, F. Broekmans, M. Eijkemans, F. H. De-jong, J. Habbema et al., Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve, Fertil Steril. févr, vol.77, issue.2, pp.328-364, 2002.

A. L. Waylen, M. Metwally, G. L. Jones, A. J. Wilkinson, and W. L. Ledger, Effects of cigarette smoking upon clinical outcomes of assisted reproduction: a meta-analysis, Hum Reprod Update. févr, vol.15, issue.1, pp.31-44, 2009.

N. Singh, P. Gupta, S. Mittal, and N. Malhotra, Correlation of body mass index with outcome of in vitro fertilization in a developing country, Arch Gynecol Obstet. janv, vol.285, issue.1, pp.259-63, 2012.

N. Malhotra, A. Bahadur, N. Singh, M. Kalaivani, and S. Mittal, Does obesity compromise ovarian reserve markers? A clinician's perspective, Arch Gynecol Obstet. janv, vol.287, issue.1, pp.161-167, 2013.

S. Halawaty, E. Elkattan, H. Azab, N. Elghamry, A. et al., Effect of obesity on parameters of ovarian reserve in premenopausal women, J Obstet Gynaecol Can JOGC J Obstet Gynecol Can JOGC. juill, vol.32, issue.7, pp.687-90, 2010.

M. Kriseman, C. Mills, E. Kovanci, H. Sangi-haghpeykar, and W. Gibbons, Antimullerian hormone levels are inversely associated with body mass index (BMI) in women with polycystic ovary syndrome, J Assist Reprod Genet. sept, vol.32, issue.9, pp.1313-1319, 2015.

O. B. Christiansen, Evidence-based investigations and treatments of recurrent pregnancy loss, Curr Opin Obstet Gynecol. juin, vol.18, issue.3, pp.304-316, 2006.

C. Y. Andersen, K. T. Schmidt, S. G. Kristensen, M. Rosendahl, A. G. Byskov et al., Concentrations of AMH and inhibin-B in relation to follicular diameter in normal human small antral follicles, Hum Reprod Oxf Engl. mai, vol.25, issue.5, pp.1282-1289, 2010.

S. M. Nelson, E. Pastuszek, G. Kloss, I. Malinowska, J. Liss et al., Two new automated, compared with two enzyme-linked immunosorbent, antimüllerian hormone assays, Fertil Steril, vol.104, issue.4, pp.1016-1021, 2015.

K. Pearson, M. Long, J. Prasad, Y. Y. Wu, and M. Bonifacio, Assessment of the Access AMH assay as an automated, high-performance replacement for the AMH Generation II manual ELISA, Reprod Biol Endocrinol RBE. 16 févr, vol.14, p.8, 2016.

, Atlas d'embryologie de l'ESHREIndex

. Eshre,

D. Sur,

, Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting, Hum Reprod Oxf Engl. juin, vol.26, issue.6, pp.1270-83, 2011.